Frequent aberrant methylation of p16(INK4a) in primary rat lung tumors

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1366-1374

  Swafford, Deborah S ^a   Middleton, Susan K ^a   Palmisano, William A ^a   Nikula, Kristen J ^a   Tesfaigzi, Johannes ^a   Baylin, Stephen B ^b   Herman, James G ^b   Belinsky, Steven A ^a  

^a Inhalation Toxicology Research Institute   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL POPULATION; DNA DETERMINATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; LUNG NON SMALL CELL CANCER; METHYLATION; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SOUTHERN BLOTTING;

ANIMALIA;

EID: 0031018480     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1366     Document Type: Article

References (50)

1. INK4a in mouse lung tumors. Carcinogenesis 17:101-106.
2. Belinsky, S. A., S. K. Middleton, S. M. Picksley, F. F. Hahn, and K. J. Nikula. 1996. Alterations in the K-ras and p53 pathways in X ray-induced lung tumors in the rat. Radiat. Res. 145:449-456.
3. Belinsky, S. A., K. J. Nikula, S. B. Baylin, and J.-P. Issa. 1996. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA 93:4045-4050.
4. Belinsky, S. A., J. F. Lechner, and N. F. Johnson. 1995. An improved method for the isolation of type II and clara cells from mice. In Vitro Cell. Dev. Biol. 31:361-366.
5. Belinsky, S. A., T. R. Devereux, J. F. Foley, R. R. Maronpot, and M. W. Anderson. 1992. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 52:3164-3173.
6. Belinsky, S. A. Unpublished data.
7. Bestor, T., A. Laudano, R. Mattaliano, and V. Ingram. 1988. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J. Mol. Biol. 203:971-983.
8. Cairns, P., T. J. Polascik, Y. Eby, K. Tokino, J. Califano, A. Merlo, L. Mao, J. Herath, R. Jenkins, W. Westra, J. L. Rutter, A. Buckler, E. Gabrielson, M. Tockman, K. R. Cho, L. Hedrick, G. S. Bova, W. Isaacs, W. Koch, D. Schwab, and D. Sidransky. 1995. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat. Genet. 11:210-212.
9. Davis, L. M., W. J. Caspary, S. A. Sakallah, R. Maronpot, R. Wiseman, J. C. Barrett, R. Elliott, and J. C. Hozier. 1994. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis 15:1637-1645.
10. Finch, G. L., K. J. Nikula, W. E. Bechtold, B. T. Chen, W. C. Griffith, F. F. Hahn, C. H. Hobbs, M. D. Hoover, D. L. Lundgren, and J. L. Mauderly. 1995. Effects of combined exposure of F344 rats to radiation and chronically inhaled cigarette smoke, p. 77-79. In Annual report of the Inhalation Toxicology Research Institute, Albuquerque, N.Mex.
11. Funaki, K., J. Everitt, M. Oshimura, J. J. Freed, A. G. Knudson, and C. Walker. 1991. Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Cancer Res. 51:4415-4422.
12. Gardiner-Garden, M., and M. Frommer. 1987. CpG islands in vertebrate genomes. J. Mol. Biol. 196:261-282.
13. Gonzalez-Zulueta, M., C. M. Bender, A. S. Yang, T. Nguyen, R. W. Beart, D. M. Van Tornout, and P. A. Jones. 1995. Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissue correlates with gene silencing. Cancer Res. 55:4531-4535.
14. Harbour, J. W., S.-L. Lai, J. Whang-Peng, A. F. Gazda, J. F. Minna, and F. J. Kave. 1988. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353-357.
15. Herman, J. G., F. Latif, W. Yongkai, M. Lerman, B. Zbar, S. Liu, D. Samid, R. Dah-Shuhn, J. R. Gnarra, W. M. Linehan, and S. B. Baylin. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700-9704.
16. Herman, J. G., J. R. Graff, S. Myöhännen, B. D. Nelkin, and S. B. Baylin. 1996. MSP: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93:9821-9826.
17. Herman, J. G. Unpublished data.
18. Herzog, C. R., R. W. Wiseman, and M. You. 1994. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res. 54:4007-4010.
19. Issa, J. P., S. B. Baylin, and S. A. Belinsky. 1996. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res. 56:3655-3658.
20. Jones, P. A. 1996. DNA methylation errors and cancer. Cancer Res. 56:2463-2467.
21. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day III, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
22. INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Cancer Res. 55:1607-1612.
23. INK4a expression in resected non-small cell lung tumors. Cancer Res. 56:3415-3420.
24. Laird, P. W., and R. Jaenisch. 1994. DNA methylation and cancer. Hum. Mol. Genet. 3:1487-1495.
25. Leheup, B. P., S. J. Federspiel, M. L. Guerry-Force, N. T. Wetherall, P. A. Commers, S. J. DiMari, and M. A. Haralson. 1989. Extracellular matrix biosynthesis by cultured fetal rat lung epithelial cells. I. Characterization of the clone and the major genetic types of collagen produced. Lab. Invest. 60:791-806.
26. Li, A. P., F. F. Hahn, P. O. Zamora, R. W. Shimizu, R. F. Henderson, A. L. Brooks, and R. Richards. 1983. Characterization of a lung epithelial cell strain with potential applications in toxicological studies. Toxicology 27:257-272.
27. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375:503-506.
28. Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282-2292.
29. Maesawa, C., G. Tamura, S. Nishizuka, S. Ogasawara, K. Ishida, M. Terashima, K. Sakata, N. Sato, K. Saito, and R. Satodate. 1996. Inactivation of CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res. 56: 3875-3878.
30. Makos, M., B. D. Nelkin, M. I. Lerman, F. Latif, B. Zbar, and S. B. Baylin. 1992. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA 89:1929-1933.
31. Makos, M., B. D. Nelkin, V. R. Chazin, W. K. Cavanee, G. M. Brodeur, and S. B. Baylin. 1993. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res. 53:2715-2718.
32. Makos, M. W., M. A. Biel, W. El Deiry, B. D. Nelkin, J.-P. Issa, W. K. Cavenee, S. J. Kuerbitz, and S. B. Baylin. 1995. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med. 1:570-577.
33. Makos, M., B. D. Nelkin, R. E. Reiter, J. R. Gnarra, J. Brooks, W. Isaacs, M. Linehan, and S. B. Baylin. 1993. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res. 53:2719-2722.
34. INK4a transcript. Cancer Res. 55:2995-2997.
35. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, E. Gabrielson, P. C. Burger, S. B. Baylin, and D. Sidransky. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1:686-692.
36. Nickel-Brady, C., F. F. Hahn, G. L. Finch, and S. A. Belinsky. 1994. Analysis of K-ras, p53, and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15:257-262.
37. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55:1448-1451.
38. INK4b/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55:1448-1451.
39. INK4a protein is restricted to the subset of lung cancer lines that retains wildtype Rb. Oncogene 9:3375-3378.
40. INK4a protein induction by 5-aza 2′ deoxycytidinc. Oncogene 11:1211-1216.
41. INK4b genes. Oncogene 11:635-645.
42. Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. 1, p. 7.6-7.9. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
44. INK4a inactivation in non-small cell lung cancer cell lines. Cancer Res. 55:6200-6209.
45. INK4 expression in primary lung cancers and cell lines. Cancer Res. 55:505-509.
46. Swafford, D. S., K. J. Nikula, C. E. Mitchell, and S. A. Belinsky. 1995. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black. Carcinogenesis 16:1215-1221.
47. Vertino, P. M., R.-W. C. Yen, J. Gao, and S. B. Baylin. 1996. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol. 16:4555-4565.
48. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
49. Xiao, S., D. Li, J. M. Corson, J. Vijg, and J. A. Fletcher. 1995. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res. 55:2968-2971.
50. Yoshiura, K., Y. Kanai, A. Ochiai, Y. Shimoyama, T. Sugimura, and S. Hirohashi. 1995. Silencing of the E-cadherin invasion-suppressor gene by CpG island methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 92:7416-7419.